A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer

References

• Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sanoda Y, Aghajanian C, et al. 2006. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecologic Oncology 103:714–718.
   PubMed Web of Science ®Google Scholar
• Amant F, Moerman P, Neven P, Timmerman D, Van LE, Vergote I. 2005. Endometrial cancer. Lancet 366:491–505.
   PubMed Web of Science ®Google Scholar
• Amit A, Schink J, Reiss A, Lowenstein L. 2011. PET/CT in gynecologic cancer: present applications and future prospects – a clinician's perspective. Obstetrics and Gynecology Clinics of North America 38:1–21.
   Google Scholar
• Antonsen SL, Loft A, Fisker R, Nielsen AL, Andersen ES, Høgdall E, et al. 2013. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. Gynecologic Oncology 129:298–303.
   PubMed Web of Science ®Google Scholar
• Benedetti Panici P, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. 2008. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. The Journal of the National Cancer Institute 100:1707–1716.
   PubMedGoogle Scholar
• Chan JK, Cheung MK, Huh WK, Osann K, Hüsain A, Teng NN, et al. 2006. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107:1823–1830.
   PubMed Web of Science ®Google Scholar
• Creasman W. 2009. Revised FIGO staging for carcinoma of the endometrium. The International Journal of Gynecology and Obstetrics 5:105–109.
   Google Scholar
• Dowdy SC, Borah BJ, Bakkum-Gamez JN, Kumar S, Weaver AL, McGree ME, et al. 2012. Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstetrics and Gynecology 120:1419–1427.
   PubMed Web of Science ®Google Scholar
• Gambhir SS. 2002. Molecular imaging of cancer with positron emission tomography. Nature Reviews Cancer 2:683–693.
   PubMed Web of Science ®Google Scholar
• Hacker FN, Friedlander LM. 2010. Uterine Cancer. In: Berek JS, Hacker FN, editors. Gynecologic Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins. p. 390.
   Google Scholar
• He F, Zhang W, Zhang H. 2013. Apoptotic signaling pathways in uteri of rats with endometrial hyperplasia induced by ovariectomy combined with estrogen. Gynecologic and Obstetric Investigation 76:51–56.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer statistics, 2010. CA: A Cancer Journal for Clinicians 60:277–300.
   PubMed Web of Science ®Google Scholar
• Kakhki VR, Shahriari S, Treglia G, Hasanzadeh M, Zakavi SR, Yousefi Z, et al. 2013. Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 23:1536–1543.
   PubMed Web of Science ®Google Scholar
• Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK, Blake P, et al. 2009. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (London, England) 373:125–136.
   PubMed Web of Science ®Google Scholar
• Konno Y, Todo Y, Minobe S, Kato H, Okamoto A, Sudo S, et al. 2011. A retrospective analysis of postoperative complications with or without para-aortic lymphadenectomy in endometrial cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 21:385–390.
   PubMed Web of Science ®Google Scholar
• Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. 2008. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecologic Oncology 109:11–18.
   PubMed Web of Science ®Google Scholar
• Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R, Elisei F, et al. 2015. Staging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping . Clinical Nuclear Medicine 40:780–785.
   PubMed Web of Science ®Google Scholar
• Solmaz U, Mat E, Dereli M, Turan V, Güngördük K, Hasdemir P, et al. 2015. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer. The Australian and New Zealand Journal of Obstetrics and Gynaecology 55:81–86.
   PubMed Web of Science ®Google Scholar
• Steiner E, Schmidt M, Weikel W, Koelbl H. 2006. Influence of diabetes mellitus and nodal distribution in endometrial cancer and correlation to clinico-pathological prognostic factors. European Journal of Gynaecological Oncology 27:477–480.
   PubMed Web of Science ®Google Scholar
• Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. 2010. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet (London, England) 375:1165–1172.
   PubMed Web of Science ®Google Scholar
• Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. 2007. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. European Journal of Nuclear Medicine and Molecular Imaging 34:392–404
   PubMed Web of Science ®Google Scholar
• Yang B, Shan B, Xue X, Wang H, Shan W, Ning C, et al. 2016. Predicting lymph node metastasis in endometrial cancer using serum CA125 combined with immunohistochemical markers PR and Ki67, and a comparison with other prediction models. PLoS One 11:e0155145–e0155112.
   PubMed Web of Science ®Google Scholar
• Ye S, Wen H, Jiang Z, Wu X. 2016. The effect of visceral obesity on clinicopathological features in patients with endometrial cancer: a retrospective analysis of 200 Chinese patients. BMC Cancer 16:209–218.
   PubMed Web of Science ®Google Scholar